1001401-60-0 Usage
General Description
"1H-1,4-Diazepine-1-carboxylic acid, hexahydro-5-Methyl-, phenylMethyl ester, (5R)-" is a chemical compound that features in the family of diazepines. This organic compound consists of a seven-membered ring with two nitrogen atoms and a carboxylic acid group. The compound's structure also features a hexahydro-5-methyl group, which indicates that it includes a six-membered ring that is completely saturated (having no double or triple bonds) and has one methyl group. Lastly, it possesses a phenylMethyl ester group, suggesting the presence of an ester functional group connected to a phenyl group. The (5R)- in its name means that it is a specific enantiomer or spatial arrangement of the molecule. Overall, this compound is characterized by its complex carbon-nitrogen ring structure and various functional groups.
Check Digit Verification of cas no
The CAS Registry Mumber 1001401-60-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,1,4,0 and 1 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1001401-60:
(9*1)+(8*0)+(7*0)+(6*1)+(5*4)+(4*0)+(3*1)+(2*6)+(1*0)=50
50 % 10 = 0
So 1001401-60-0 is a valid CAS Registry Number.
1001401-60-0Relevant articles and documents
NOVEL ROUTES OF SYNTHESIS FOR THE PREPARATION OF SUVOREXANT
-
Page/Page column 133; 135, (2016/04/26)
The present invention relates to a process for the preparation of a compound of formula (A), Further, the present invention relates to the respective compound (A) as such and to its use in the preparation of antifungal agent.
SUBSTITUTED DIAZEPAN OREXIN RECEPTOR ANTAGONISTS
-
Page/Page column 33, (2008/06/13)
The present invention is directed to substituted diazepan compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved.